Pharmafile Logo
Pharmafocus logo
Advanced Search
NICE image

NICE to assess drug value

March 22, 2013
Sales and Marketing EMIG, NHS, NICE, VBP

NICE will be responsible for assessing the full value of medicines – taking into account their benefit to patients and …

News
Astrazeneca image

AstraZeneca sets out growth strategy

March 21, 2013
Sales and Marketing AstraZeneca, R&D

AstraZeneca has set out an ambitious plan designed to return it to growth which eschews diversification and sets great store …

News

Budget 2013: pharma ‘pleased’

March 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Budget, Osborne, UK

Pharma and health bodies have broadly given George Osborne’s Budget a warm welcome, with cuts in corporation tax, increased R&D …

News
steven_burrill-headshot-cropped

Targacept makes changes to Board and management

March 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targacept

Clinical-stage biopharma firm Targacept has announced several changes to its Board of directors and management. By the end of May …

Appointment
Victoza image

Underwhelming results for Victoza

March 20, 2013
Sales and Marketing Novo Nordisk, Victoza, diabetes

Novo Nordisk has reported underwhelming results for a well-established diabetes treatment in a late-stage trial designed to test its weight …

News

MPs: NHS must be ‘re-imagined’

March 20, 2013
Sales and Marketing Dorrell, NHS

Increasing cost pressure on the NHS will lead to a breakdown in health and social care services unless commissioning becomes …

News
screen_shot_2013-03-20_at_09

Ziarco appoints John LaMattina as R&D advisor

March 20, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing LaMattina, Ziarco

Ex-global head of Pfizer R&D and Pharmafocus regular John LaMattina has been given a strategic advisory role by biotech firm …

Appointment

Knee trial for Merck KGaA

March 19, 2013
Research and Development, Sales and Marketing Merck KGaA, knee, nordic

Merck KGaA is to begin a Phase IIb trial of its investigational drug sprifermin in patients with osteoarthritis (OA) of …

News
Astrazeneca image

AstraZeneca restructures global R&D

March 19, 2013
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, R&D

AstraZeneca is restructuring its global operations in a bid to improve the productivity of its R&D operations. The firm is …

News

New associate director for PAN

March 19, 2013
Medical Communications, Sales and Marketing Pan

Creative comms agency PAN has announced that Sarah Verhoeff has joined the firm from Havas Life as an associate director.Verhoeff …

Appointment
cobalt salts image

ECHA examines safety of cobalt salts used in pharma manufacturing

March 19, 2013
Manufacturing and Production ECHA, cobalt

The European Chemicals Agency (ECHA) is looking into the safety of five cobalt salts that have applications in pharmaceutical manufacturing. …

News
Euro image

EU publishes final GDP guidelines

March 19, 2013
Manufacturing and Production EC, EU, GDP

The European Commission has published the final version of its long-awaited guidelines on Good Distribution Practice (GDP), replacing an earlier …

News
NHS image

Hunt: ‘Listen to patients’

March 18, 2013
Sales and Marketing Hunt, NHS

A review of NHS complaints handling, aimed at ensuring that all hospitals listen to and act upon the concerns of …

News

Doctors body joins AllTrials

March 18, 2013
Medical Communications, Sales and Marketing alltrials, faculty

The Faculty of Pharmaceutical Medicine has signed up to AllTrials in the latest boost for the campaign for greater trial …

News

Britannia Pharma appoints marketing director

March 18, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing britannia

Britannia Pharmaceuticals (part of the STADA Arzneimittel group of companies) has appointed Robert Wood as marketing director, for international markets. …

Appointment
Witty image

GSK’s Witty: ‘Drugs should be cheaper’

March 15, 2013
Manufacturing and Production, Research and Development, Sales and Marketing ABPI, GSK, Witty

Drugs should be cheaper, GlaxoSmithKline boss Sir Andrew Witty said at a conference this week. His comments, reported by Reuters, …

News
screen_shot_2013-03-15_at_10

BASF makes organisational changes

March 15, 2013
Manufacturing and Production, Research and Development, Sales and Marketing BASF

Leading chemical firm BASF has made a series of appointments in order to reorganise its business operations. Strengthening the Asia-Pacific …

Appointment

Pulse mistake costs Astellas

March 15, 2013
Medical Communications, Sales and Marketing ABPI, Astellas, PMCPA, pulse

A mistake by medical journal Pulse has landed Astellas Pharma in hot water with the PMCPA, enforcers of the ABPI …

News
merck image

Merck makes Alzheimer’s deal

March 14, 2013
Research and Development, Sales and Marketing Alzheimer's, Merck

Merck is teaming up with Texas-based Luminex Corporation to develop a companion diagnostic to help in its dementia programme. The …

News
J&J image

J&J opens London hub

March 14, 2013
Medical Communications, Research and Development, Sales and Marketing J&J, JJ, London, research

Johnson & Johnson has opened the doors to a new life sciences centre in London that forms part of a …

News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026